Group One Trading’s X4 Pharmaceuticals XFOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.6K | Sell |
3,998
-1,739
| -30% | -$3.3K | ﹤0.01% | 1621 |
|
|
2025
Q1 | $40.7K | Sell |
5,737
-20,843
| -78% | -$148K | ﹤0.01% | 1183 |
|
|
2024
Q4 | $585K | Buy |
26,580
+22,397
| +535% | +$493K | ﹤0.01% | 609 |
|
|
2024
Q3 | $84K | Sell |
4,183
-1,292
| -24% | -$25.9K | ﹤0.01% | 903 |
|
|
2024
Q2 | $95.3K | Buy |
5,475
+4,767
| +673% | +$82.9K | ﹤0.01% | 849 |
|
|
2024
Q1 | $29.5K | Sell |
708
-1,651
| -70% | -$68.9K | ﹤0.01% | 1067 |
|
|
2023
Q4 | $59.3K | Sell |
2,359
-5,186
| -69% | -$130K | ﹤0.01% | 1035 |
|
|
2023
Q3 | $247K | Sell |
7,545
-3,319
| -31% | -$109K | ﹤0.01% | 692 |
|
|
2023
Q2 | $632K | Buy |
10,864
+9,854
| +976% | +$574K | ﹤0.01% | 431 |
|
|
2023
Q1 | $26.4K | Buy |
1,010
+337
| +50% | +$8.8K | ﹤0.01% | 1154 |
|
|
2022
Q4 | $20K | Sell |
673
-423
| -39% | -$12.6K | ﹤0.01% | 1302 |
|
|
2022
Q3 | $56K | Buy |
+1,096
| New | +$56K | ﹤0.01% | 1194 |
|
|
2022
Q2 | – | Sell |
-565
| Closed | -$30K | – | 3375 |
|
|
2022
Q1 | $30K | Buy |
565
+107
| +23% | +$5.68K | ﹤0.01% | 1553 |
|
|
2021
Q4 | $31K | Buy |
458
+389
| +564% | +$26.3K | ﹤0.01% | 1695 |
|
|
2021
Q3 | $11K | Buy |
+69
| New | +$11K | ﹤0.01% | 1822 |
|